Cargando…

Usefulness of tocilizumab for treating rheumatoid arthritis with myelodysplastic syndrome: A case report and literature review

RATIONALE: Dysregulated immune function in rheumatoid arthritis (RA) might lead to the development of myelodysplastic syndrome (MDS). Serum interleukin-6 (IL-6) concentrations are increased in both RA and MDS patients. PATIENT CONCERNS: A 58-year-old woman presented with severe RA. During a recent 8...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Chuanyin, Luo, Yingwan, Tong, Hongyan, Xu, Guanhua, Lin, Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023877/ https://www.ncbi.nlm.nih.gov/pubmed/29924032 http://dx.doi.org/10.1097/MD.0000000000011179

Ejemplares similares

Malignancy rates in patients with rheumatoid arthritis treated with tocilizumab
por: Rubbert-Roth, Andrea, et al.
Publicado: (2016)

Rheumatoid arthritis associated with myelodysplastic syndrome: a case report.
por: Nam, E. J., et al.
Publicado: (1999)

A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab
por: Cai, Shaozhe, et al.
Publicado: (2020)

The clinical value of hematological markers in rheumatoid arthritis patients treated with tocilizumab
por: Zhou, Li, et al.
Publicado: (2019)

Review of tocilizumab in the treatment of rheumatoid arthritis
por: Okuda, Yasuaki
Publicado: (2008)

Tocilizumab in the treatment of rheumatoid arthritis and beyond
por: Shetty, Anjali, et al.
Publicado: (2014)

Tocilizumab: A Review in Rheumatoid Arthritis
por: Scott, Lesley J.
Publicado: (2017)

Hypoplastic Myelodysplastic Syndrome: Symptom of Methotrexate Toxicity in Rheumatoid Arthritis
por: Khan, Adil, et al.
Publicado: (2023)

Safety and Efficacy of Tocilizumab for the Treatment of Rheumatoid Arthritis
por: Ogata, Atsushi, et al.
Publicado: (2012)

Longitudinal immunomonitoring following Tocilizumab in rheumatoid arthritis
por: Pers, Yves-Marie, et al.
Publicado: (2011)

Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes
por: Yan, Xuefen, et al.
Publicado: (2021)

Serial monitoring of circulating tumour DNA on clinical outcome in myelodysplastic syndromes and acute myeloid leukaemia
por: Zhou, Xinping, et al.
Publicado: (2023)

Efficacy of subcutaneous tocilizumab in patients with rheumatoid arthritis and systemic sclerosis overlap syndrome: a report of two cases and review of the literature
por: Wakabayashi, Hiroki, et al.
Publicado: (2019)

Hepatotoxicity due to tocilizumab and anakinra in rheumatoid arthritis: two case reports
por: Mahamid, Mahmud, et al.
Publicado: (2011)

Hepatitis E during Tocilizumab Therapy in a Patient with Rheumatoid Arthritis: Case Report and Literature Review
por: Ikeuchi, Hidekazu, et al.
Publicado: (2018)

Laboratory and febrile features after joint surgery in patients with rheumatoid arthritis treated with tocilizumab
por: Hirao, M, et al.
Publicado: (2008)

Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series
por: Talotta, Rossella, et al.
Publicado: (2018)

Comprehensive exploratory autoantibody profiling in patients with early rheumatoid arthritis treated with methotrexate or tocilizumab
por: Teitsma, Xavier M., et al.
Publicado: (2020)

Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions
por: Mahamid, Mahmud, et al.
Publicado: (2011)

Early intervention in the treatment of rheumatoid arthritis: focus on tocilizumab
por: Yilmaz, Sedat, et al.
Publicado: (2013)

Refining the Management of Rheumatoid Arthritis: the Benefits of Subcutaneous Tocilizumab
por: Negoescu, Andra F., et al.
Publicado: (2014)

Tocilizumab-Induced Dermatosis in a Patient With Rheumatoid Arthritis
por: Babkoor, Doaa, et al.
Publicado: (2022)

Rituximab and lenalidomide combination treatment for rheumatoid arthritis complicated with myelodysplastic syndrome: A case report
por: Evangelatos, Gerasimos, et al.
Publicado: (2017)

H syndrome treated with Tocilizumab: two case reports and literature review
por: Jacquot, Robin, et al.
Publicado: (2023)

Efficacy and safety of tocilizumab in Korean patients with active rheumatoid arthritis
por: Baek, Han Joo, et al.
Publicado: (2019)

Mutation status and burden can improve prognostic prediction of patients with lower‐risk myelodysplastic syndromes
por: Jiang, Lingxu, et al.
Publicado: (2019)

Targeting miR‐126 disrupts maintenance of myelodysplastic syndrome stem and progenitor cells
por: Wang, Huafeng, et al.
Publicado: (2021)

Serum level of oxidative stress marker is dramatically low in patients with rheumatoid arthritis treated with tocilizumab
por: Hirao, Makoto, et al.
Publicado: (2011)

Concomitant Use of Statins in Tocilizumab-Treated Patients with Rheumatoid Arthritis: A Post Hoc Analysis
por: Soubrier, Martin, et al.
Publicado: (2016)

Critical appraisal of tocilizumab in the treatment of moderate to severe rheumatoid arthritis
por: Hushaw, Linda L, et al.
Publicado: (2010)

Tocilizumab: A Review of Its Safety and Efficacy in Rheumatoid Arthritis
por: Jones, Graeme, et al.
Publicado: (2010)

Current perspectives on tocilizumab for the treatment of rheumatoid arthritis: a review
por: Al-Shakarchi, Israa, et al.
Publicado: (2013)

Progressive Multifocal Leukoencephalopathy during Tocilizumab Treatment for Rheumatoid Arthritis
por: Anada, Mamiko, et al.
Publicado: (2020)

Tocilizumab Effects on Coagulation Factor XIII in Patients with Rheumatoid Arthritis
por: Gualtierotti, Roberta, et al.
Publicado: (2019)

Organizing Pneumonia Induced by Tocilizumab in a Patient with Rheumatoid Arthritis
por: Gouveia, Pedro A, et al.
Publicado: (2020)

Safety and tolerability of subcutaneous sarilumab and intravenous tocilizumab in patients with rheumatoid arthritis
por: Emery, Paul, et al.
Publicado: (2019)

Secondary Failure of Tocilizumab in Treating Elderly-Onset Rheumatoid Arthritis With Systemic Symptoms Complicated by Diverticulum Perforation
por: Takagi, Soshi, et al.
Publicado: (2022)

Durability of Response to Tocilizumab Therapy in Rheumatoid Arthritis: Data from the US-Based Corrona Rheumatoid Arthritis Registry
por: Pappas, Dimitrios A., et al.
Publicado: (2021)

Tocilizumab in the Treatment of Rheumatoid Arthritis: A Cost-Effectiveness Analysis in the UK
por: Diamantopoulos, Alex, et al.
Publicado: (2014)

Tocilizumab Induced Acquired Factor XIII Deficiency in Patients with Rheumatoid Arthritis
por: Mokuda, Sho, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ujsdeqnf3na4adfg8vitc7j3li